Tedco awards $600K to tech firms - Kansas City Business Journal:

vykyvimote.wordpress.com
The money was granted in collaboration withthe U.S. Army Medica Research and Materiel Command and the throug hthe Ft. Detrick Technology Transfer Initiative. The purpose of the technology transfer prograjm is to raise awareness of new and developing technologies and funding them to transitionh as viable projectsfor follow-on funding in the market Each company that received funding was awarded approximateluy $50,000 between March 2008 and May 2009, makin up the initiative’s second round of financiakl awards since its $750,000 program extension. The fundx for the program’s second phass were secured by Sen. Barbara D-Md., and Rep. Roscoe G. Bartlett, R-Md. “The [Ft.
Detrickl Technology Transfer Initiative] program is enabling area businesses to harness the technologiews being developed at Fort Detrick and apply them to thecommercial sector,” said Mikulski. “This will lead to new productz that have the power to create jobs andsave lives.” Mikulsku announced the first phase of the tech transfer prograk in March 2005 when 11 companiesd received funding. in Rockville: The compang is developing a health care technology callecdmiTag system, which is a scalable wireless sensod solution for improving patient flow. in Frederick: The company is developinv a technology called the GeNova Screento isolate, and produce antibody-like molecules.
in The company is developing an on-demanr biotech products including a combinatiobn vaccine against plagueand anthrax. BioAssay Worksw LLC in Ijamsville: The company is developing a lateral-floq visual diagnostic test to detecrt and differentiate single sample multiplepathogenic poxviruses, includinvg variola, vaccinia, and monkeypox. in Catonsville: The compan y is safety-testing a medical product callexd ClotFoam, which is a intracavitary hemostatic agent.
CynerGene IDMP in Frederick: The companhy is developing, validating and implementing a supplementap diagnosisof Malaria, HIV, and Dengue using its Infectiouas Disease Multiplex Panel which could allow for creation of LLC in Baltimore: The company is developing requiredd components and system framework to enable conversational interfacews for telemedicine tools. Such toolas would allow professional medics touse gesture, and other human-- computer interactions to accesas and document information in electronic medica records. in Rockville: The company is developingg technology to preserve mammalian cella in dried format that can easilybe re-hydrateds for a variety of uses.
LLC in The company is evaluatingy the effect of Imagilin patented probiotices as a food supplement to enhance the immune responsivenesas of guinea pigs upon immunization or challenge withvirulent pathogens. The evaluatiojn will suggest the ability of Imagilin patented probiotics to enhance the immunization ofa vaccine. in Baltimore: The company is developing micropatterned substrates for viralinfectivithy assays. Juxtopia in Baltimore: The company is customizing its Wearable Assistance and SituationaoAwareness (WASA) goggles and service to allow U.S. Army combatt medics to access and document informationm to electrical medical recordavia hands-free voice-requests and voice-responses.
in The company is developing cell therapies to treaty brain and spinalcord injuries.